BridgeBio Pharma
BBIO
#1405
Rank
S$19.10 B
Marketcap
S$98.08
Share price
-2.75%
Change (1 day)
10.26%
Change (1 year)

Earnings for BridgeBio Pharma (BBIO)

Earnings in 2026 (TTM): -S$0.47 Billion

According to BridgeBio Pharma 's latest financial reports the company's current earnings are S$0.94 Billion. In 2025 the company made an earning of -S$0.72 Billion a decrease over its 2024 earnings that were of -S$0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BridgeBio Pharma from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.47 Billion-34.64%
2025 -S$0.72 Billion25.14%
2024 -S$0.58 Billion-22.56%
2023 -S$0.74 Billion41.5%
2022 -S$0.53 Billion-25.1%
2021 -S$0.7 Billion15.11%
2020 -S$0.61 Billion67.55%
2019 -S$0.37 Billion67.65%
2018 -S$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion-56.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.43 Million-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA